Walter Lau Wa To
Director/Board Member at Birdie Biotech, Inc.
Profile
Walter Lau Wa To currently works at Oriengene Biotechnology Ltd., as Director, Birdie Biotech, Inc., as Director, Huapu Biotechnology Co., Ltd., as Director, Curegenix, Inc., as Director, and Start Shanghai Co., Ltd., as Director.
Dr. Wa To also formerly worked at Taiwan Liposome Co., Ltd., as Independent Director.
Dr. Wa To received his undergraduate degree from California Institute of Technology and doctorate degree from the University of California, Berkeley.
Walter Lau Wa To active positions
Companies | Position | Start |
---|---|---|
Birdie Biotech, Inc.
Birdie Biotech, Inc. Medical SpecialtiesHealth Technology Birdie Biotech, Inc. develops novel targeted therapies for the treatment of cancer. The firm discovers, develops, and delivers innovative human therapeutics and break through a novel drug conjugation technology and to create new generation of targeted therapies. The company is headquartered in Beijing, China. | Director/Board Member | - |
Huapu Biotechnology Co., Ltd. | Director/Board Member | - |
Oriengene Biotechnology Ltd.
Oriengene Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Oriengene Biotechnology Ltd. develops drugs to treat cancer. | Director/Board Member | - |
Curegenix, Inc. | Director/Board Member | - |
Start Shanghai Co., Ltd. | Director/Board Member | - |
Former positions of Walter Lau Wa To
Companies | Position | End |
---|---|---|
TAIWAN LIPOSOME COMPANY, LTD. | Director/Board Member | - |
Training of Walter Lau Wa To
California Institute of Technology | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Linked companies
Private companies | 6 |
---|---|
Taiwan Liposome Co., Ltd.
Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
Oriengene Biotechnology Ltd.
Oriengene Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Oriengene Biotechnology Ltd. develops drugs to treat cancer. | Health Technology |
Birdie Biotech, Inc.
Birdie Biotech, Inc. Medical SpecialtiesHealth Technology Birdie Biotech, Inc. develops novel targeted therapies for the treatment of cancer. The firm discovers, develops, and delivers innovative human therapeutics and break through a novel drug conjugation technology and to create new generation of targeted therapies. The company is headquartered in Beijing, China. | Health Technology |
Huapu Biotechnology Co., Ltd. | |
Curegenix, Inc. | |
Start Shanghai Co., Ltd. |
- Stock Market
- Insiders
- Walter Lau Wa To